Diseases, Conditions, Syndromes

New receptor 'decoy' drug neutralizes COVID-19 virus and its variants

Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant. The drug ...

Neuroscience

Findings open way for personalized multiple sclerosis treatment

Currently available therapies to treat multiple sclerosis (MS) lack precision and can lead to serious side effects. Researchers at Karolinska Institutet in Sweden have now developed a method for identifying the immune cells ...

page 9 from 40